ZOAVE Trademark

Trademark Overview


On Tuesday, December 14, 2021, a trademark application was filed for ZOAVE with the United States Patent and Trademark Office. The USPTO has given the ZOAVE trademark a serial number of 97171522. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, August 19, 2024. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The ZOAVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the following systems and organs: autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, integumentary system diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, contraception, drug dependence, fertility disorders, hormone replacement, infectious diseases due to bacteria, viruses, fungi, parasites, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychologi...
zoave

General Information


Serial Number97171522
Word MarkZOAVE
Filing DateTuesday, December 14, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the following systems and organs: autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, integumentary system diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, contraception, drug dependence, fertility disorders, hormone replacement, infectious diseases due to bacteria, viruses, fungi, parasites, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Friday, December 17, 2021NEW APPLICATION ENTERED
Friday, December 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 25, 2022ASSIGNED TO EXAMINER
Wednesday, June 1, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 1, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, June 1, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 1, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, June 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 15, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 5, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 30, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 14, 2023SOU EXTENSION 1 FILED
Tuesday, February 14, 2023SOU EXTENSION 1 GRANTED
Tuesday, February 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 27, 2024SOU EXTENSION 3 FILED
Tuesday, February 27, 2024SOU EXTENSION 3 GRANTED
Thursday, February 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 16, 2023SOU EXTENSION 2 FILED
Wednesday, August 16, 2023SOU EXTENSION 2 GRANTED
Friday, August 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2024SOU EXTENSION 4 GRANTED
Monday, August 19, 2024SOU EXTENSION 4 FILED
Wednesday, February 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED